Eiken Chemical Co., Ltd.
Research Eiken Chemical Co., Ltd. (4549.T) on Bullrun: market cap JPY 83.07B, P/E 23.4, dividend yield 2.4%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker4549.T
- ExchangeTSE
- CountryJapan
- SectorHealthcare
- IndustryMedical Devices
- CurrencyJPY
- Market capJPY 83.07B
- P/E23.4
- Dividend yield2.4%
- Financial periodFY2026
- RevenueJPY 41.90B
- Revenue growth3.4%
- Net incomeJPY 3.71B
- Free cash flow-JPY 1.92B
- Gross margin38.6%
Valuation Snapshot
latest market cap is JPY 83.07B; P/E is 23.4; dividend yield is 2.4%.
Peer valuation comparison
Latest P/E is 23.44x versus a Healthcare sector median of 21.69x (8.0% above).
Latest dividend yield is 2.41% versus a Healthcare sector median of 2.41%.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2026 | JPY 41.90B | JPY 3.71B | -JPY 1.92B | 38.6% | 112.08 | JPY 10.94B | JPY 7.29B | JPY 44.03B |
| FY2025 | JPY 40.54B | JPY 2.23B | JPY 655.00M | 40.7% | 64.27 | JPY 9.87B | JPY 4.47B | JPY 43.60B |
| FY2024 | JPY 40.05B | JPY 2.63B | JPY 1.72B | 41.8% | 71.1 | JPY 16.31B | JPY 4.34B | JPY 45.97B |
| FY2023 | JPY 43.27B | JPY 5.74B | JPY 4.30B | 47.4% | 153.86 | JPY 18.32B | JPY 4.31B | JPY 49.53B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | JPY 83.07B | 23.4 | 2.3% | 58 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 58 JPY, yield 2.4%.
| Year | Dividends/share |
|---|---|
| FY2026 | 58 JPY |
| FY2025 | 56 JPY |
| FY2024 | 52 JPY |
| FY2023 | 52 JPY |
| FY2022 | 55 JPY |
About Eiken Chemical Co., Ltd.
Eiken Chemical Co., Ltd. engages in the manufacture and sale of clinical diagnostics in Japan. It offers microbiological reagents for diagnosis of microorganism infection, such as mediums, antimicrobial susceptibility, and rapid test reagents; urinalysis test strips for occult blood, protein, and glucose; and fecal immunochemical tests reagents for screening of colorectal cancer.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Eiken Chemical Co., Ltd.'s market cap?
Eiken Chemical Co., Ltd.'s market capitalization is JPY 83.07B.
What is Eiken Chemical Co., Ltd.'s P/E ratio?
Eiken Chemical Co., Ltd.'s price-to-earnings (P/E) ratio is 23.4.
Does Eiken Chemical Co., Ltd. pay a dividend?
Eiken Chemical Co., Ltd. has a dividend yield of 2.4%.
What does Eiken Chemical Co., Ltd. do?
Eiken Chemical Co., Ltd. engages in the manufacture and sale of clinical diagnostics in Japan. It offers microbiological reagents for diagnosis of microorganism infection, such as mediums, antimicrobial susceptibility, and rapid test reagents; urinalysis test strips for occult blood, protein, and glucose; and fecal immunochemical tests reagents for screening of colorectal cancer.